Kinase overexpressing cancers responsive to drug withdrawal

Aging (Albany NY). 2015 Oct;7(10):752-3. doi: 10.18632/aging.100830.

Authors

Amit Dipak Amin¹, Soumya S Rajan², Jonathan H Schatz¹

Affiliations

¹ Department of Medicine, Division of Hematology-Oncology, Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, FL 33136, USA.
² Sheila and David Fuente Graduate Program in Cancer Biology, University of Miami Miller School of Medicine, Miami, FL 33136, USA.

No abstract available

Keywords: ALK; BRAF; cancer therapeutics; oncogene overdose.

Publication types

Editorial

MeSH terms

Animals
Antineoplastic Agents / administration & dosage*
Drug Resistance, Neoplasm*
Humans
Neoplasms / drug therapy*
Neoplasms / enzymology
Protein Kinase Inhibitors / administration & dosage*

Substances

Antineoplastic Agents
Protein Kinase Inhibitors

Grants and funding

R01 CA190696/CA/NCI NIH HHS/United States